Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;70(5):607-623.
doi: 10.1007/s12026-022-09290-z. Epub 2022 May 24.

Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors

Sumra Komal  1 , Nimrah Komal  2 , Ali Mujtaba  2 , Shu-Hui Wang  1 , Li-Rong Zhang  1 , Sheng-Na Han  3
Affiliations
Review

Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors

Sumra Komal et al. Immunol Res. 2022 Oct.

Abstract

Myocardial infarction (MI) is a life-threatening condition among patients with cardiovascular diseases. MI increases the risk of stroke and heart failure and is a leading cause of morbidity and mortality worldwide. Several genetic and epigenetic factors contribute to the development of MI, suggesting that further understanding of the pathomechanism of MI might help in the early management and treatment of this disease. Toll-like receptors (TLRs) are well-known members of the pattern recognition receptor (PRR) family and contribute to both adaptive and innate immunity. Collectively, studies suggest that TLRs have a cardioprotective effect. However, prolonged TLR activation in the response to signals generated by damage-associated molecular patterns (DAMPs) results in the release of inflammatory cytokines and contributes to the development and exacerbation of myocardial inflammation, MI, ischemia-reperfusion injury, myocarditis, and heart failure. The objective of this review is to discuss and summarize the association of TLRs with MI, highlighting their therapeutic potential for the development of advanced TLR-targeted therapies for MI.

Keywords: Biomarkers; Cardiovascular diseases; Myocardial infarction; Pathophysiology; Toll-like receptors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mähönen M, Ngu Blackett K, Lisheng L. Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction. World Health Organization Definition of Myocardial Infarction: 2008–09 Revision. Int J Epidemiol. 2011;40(1):139–46. https://doi.org/10.1093/ije/dyq165 . - DOI - PubMed
    1. Havranek EP, Mujahid MS, Barr DA, Blair IV, Cohen MS, Cruz-Flores S, Davey-Smith G, Dennison-Himmelfarb CR, Lauer MS, Lockwood DW, Rosal M, Yancy CW. Social determinants of risk and outcomes for cardiovascular disease. Circulation. 2015;132(9):873–98. https://doi.org/10.1161/CIR.0000000000000228 . - DOI - PubMed
    1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, De Ferranti SD, Floyd J, Fornage M, Gillespie C. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603. - PubMed - PMC - DOI
    1. Nakatani D, Sakata Y, Suna S, Usami M, Matsumoto S, Shimizu M, Sumitsuji S, Kawano S, Ueda Y, Hamasaki T. Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction. Circ J 2012, CJ-11.
    1. Kim HO, Kim JM, Woo JS, Beom Park C, Man Cho J, Lee SU, Kim CJ, Jeong MH, Kim W, KAMIR Investigators. Circadian distribution of acute myocardial infarction in different age groups. Am J Cardiol. 2018;121(11):1279–84. - PubMed - DOI

Publication types

LinkOut - more resources